Bids For Pharma Wholesaler In Hungary
The Budapest City Council in Hungary is to consider two bids for the purchase of the pharmaceutical producer and wholesaler, Pharmafontana, according to MTI Econews. The council is sole owner of the business, which has a registered share capital of 3.2 billion forint ($1.3 million).
Five bids were received for the purchase of a 50% plus one vote stake in Pharmafontana, but only two bids were considered valid. One of the valid bids came from Kaiser and Kraft, a subsidiary of the German group Gehe. The other was submitted by the Hungarian Naturland health supplements producer. A previous attempt to sell a majority stake failed last fall.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze